Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00994201 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response

A clinical trial, sponsored by OHSU Knight Cancer Institute.

Terminated
Registry status
10
Enrollment target

NCT00994201: Clinical Trial study, sponsored by OHSU Knight Cancer Institute.

NCT00994201 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00994201 was terminated before completion, sponsored by OHSU Knight Cancer Institute.

TERMINATED
Registry status
10 participants
Enrollment target

Study Summary

The purpose of this study is to see if new techniques of measuring HNSCC tumors with magnetic resonance imaging (MRI) can help predict how well the tumors will respond to combined chemotherapy and radiation treatment. The investigators hope to find a reliable method to determine whether or not a patient's cancer is responding to chemo-radiation early in their treatment using an MRI, such that that cancer treatments could be tailored to the individual more effective in the future. The MRI techniques include dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), diffusion-weighted magnetic resonance imaging (DW-MRI), and magnetic resonance spectroscopy (MRS). Participants will be subjected to two sessions of MRI scans: one before the initiation of their regular treatment and the second before their second cycle of chemotherapy. Each scanning session will last approximately 45 minutes.

Interventions

  • OTHER DCE-MRI, DW-MRI and MRS

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2011-10
Est. Completion 2015-06
OHSU Knight Cancer Institute

211 total trials

Why NCT00994201 stopped before completion

NCT00994201 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which DCE-MRI, DW-MRI and MRS is the first listed.

NCT00994201 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00994201 about?

NCT00994201 is a clinical study titled "Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response". The purpose of this study is to see if new techniques of measuring HNSCC tumors with magnetic resonance imaging (MRI) can help predict how well the tumors will respond to combined chemotherapy and radiation treatment. The investigators hope to find a reliable method to determine whether or not a pat...

What is the current status of trial NCT00994201?

This trial is currently terminated. The enrollment target is 10 participants. The study started on 2011-10. Estimated completion is 2015-06.

What interventions are being tested in trial NCT00994201?

The interventions under investigation include: DCE-MRI, DW-MRI and MRS (OTHER).

Who is sponsoring clinical trial NCT00994201?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00994201, the US trial registry maintained by the National Library of Medicine. NCT00994201 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.